T CELL RECEPTORS TARGETING Y220C OR R175H MUTATION IN P53
Patent Cooperation Treaty
PCT/US2024/021425
Filed on 2024-03-26
PCT/US2024/021425
Filed on 2024-03-26
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS
Russia
202091335
Filed on 2020-06-26
202091335
Filed on 2020-06-26
Methods for the Treatment of Kaposi's Sarcoma or KSHV-Induced Lymphoma Using Immunomodulatory Compounds, and Uses of Biomarkers
Slovenia
16815375.7
Filed on 2017-12-21
16815375.7
Filed on 2017-12-21
Methods for the Treatment of Kaposi's Sarcoma or KSHV-Induced Lymphoma Using Immunomodulatory Compounds, and Uses of Biomarkers
Austria
16815375.7
Filed on 2017-12-21
16815375.7
Filed on 2017-12-21
Methods for the Treatment of Kaposi's Sarcoma or KSHV-Induced Lymphoma Using Immunomodulatory Compounds, and Uses of Biomarkers
Czech Republic
16815375.7
Filed on 2017-12-21
16815375.7
Filed on 2017-12-21
Methods for the Treatment of Kaposi's Sarcoma or KSHV-Induced Lymphoma Using Immunomodulatory Compounds, and Uses of Biomarkers
Slovakia
16815375.7
Filed on 2017-12-21
16815375.7
Filed on 2017-12-21
Methods for the Treatment of Kaposi's Sarcoma or KSHV-Induced Lymphoma Using Immunomodulatory Compounds, and Uses of Biomarkers
Switzerland
16815375.7
Filed on 2017-12-21
16815375.7
Filed on 2017-12-21
Methods for the Treatment of Kaposi's Sarcoma or KSHV-Induced Lymphoma Using Immunomodulatory Compounds, and Uses of Biomarkers
Greece
16815375.7
Filed on 2017-12-21
16815375.7
Filed on 2017-12-21
Methods for the Treatment of Kaposi's Sarcoma or KSHV-Induced Lymphoma Using Immunomodulatory Compounds, and Uses of Biomarkers
Hungary
16815375.7
Filed on 2017-12-21
16815375.7
Filed on 2017-12-21
Methods for the Treatment of Kaposi's Sarcoma or KSHV-Induced Lymphoma Using Immunomodulatory Compounds, and Uses of Biomarkers
Ireland
16815375.7
Filed on 2017-12-21
16815375.7
Filed on 2017-12-21